Figures & data
Table 1. Different methods used for biofilm quantification.
Table 2. Different anti-biofilm molecules and their target bacteria.
Table 3. Mechanisms followed by different Anti-biofilm molecules.
Figure 2. Structures of the anti-biofilm molecules that inhibit AHL-mediated quorum sensing. (a) EGCGCitation263, (b) QuercetinCitation264, (c) Synthetic halogenated furanoneCitation265, (d) ReserpineCitation266, (e) CurcuminCitation267, (f) Ellagic acidCitation268, (g) Tannic acidCitation269.
![Figure 2. Structures of the anti-biofilm molecules that inhibit AHL-mediated quorum sensing. (a) EGCGCitation263, (b) QuercetinCitation264, (c) Synthetic halogenated furanoneCitation265, (d) ReserpineCitation266, (e) CurcuminCitation267, (f) Ellagic acidCitation268, (g) Tannic acidCitation269.](/cms/asset/726d99a8-f42f-4009-9122-1a698ffea6ac/kvir_a_1313372_f0002_b.gif)
Figure 3. Structures of the anti-biofilm molecules that inhibit the stringent response. (a) EugenolCitation270.
![Figure 3. Structures of the anti-biofilm molecules that inhibit the stringent response. (a) EugenolCitation270.](/cms/asset/7fa31adf-b8d0-41ba-8864-771ae94d3f24/kvir_a_1313372_f0003_b.gif)
Figure 4. Structure of anti biofilm molecules that disassemble the biofilm. (a) BerberineCitation271, (b) Usnic acidCitation272.
![Figure 4. Structure of anti biofilm molecules that disassemble the biofilm. (a) BerberineCitation271, (b) Usnic acidCitation272.](/cms/asset/9ff290eb-287c-4f59-8d42-860ec1938b8d/kvir_a_1313372_f0004_b.gif)
Figure 5. Structures of the anti-biofilm molecules that inhibit lipopolysachharides. (a) Colistin (Polymixin E)Citation273, (b) Polymixin B274,275, (c) Gramicidin S276, (d) Sushi peptide (S1 domain)Citation181.
![Figure 5. Structures of the anti-biofilm molecules that inhibit lipopolysachharides. (a) Colistin (Polymixin E)Citation273, (b) Polymixin B274,275, (c) Gramicidin S276, (d) Sushi peptide (S1 domain)Citation181.](/cms/asset/ed5a0d59-70f0-4cc8-baa2-7cf82c2d9ee7/kvir_a_1313372_f0005_b.gif)
Figure 6. Structures of the anti-biofilm molecules that alter the membrane potential or membrane permeabilization. (a) NisinCitation277,278, (b) SubtilinCitation279, (c) EpiderminCitation280, (d) GalliderminCitation281, (e) ChlorhexidineCitation282, (f) SophorolipidCitation283, (g) Polyhexamethylene biguanideCitation284.
![Figure 6. Structures of the anti-biofilm molecules that alter the membrane potential or membrane permeabilization. (a) NisinCitation277,278, (b) SubtilinCitation279, (c) EpiderminCitation280, (d) GalliderminCitation281, (e) ChlorhexidineCitation282, (f) SophorolipidCitation283, (g) Polyhexamethylene biguanideCitation284.](/cms/asset/c5b75241-dcbd-4e8d-b472-73acc454b2ae/kvir_a_1313372_f0006_b.gif)
Figure 7. Structures of the anti-biofilm molecules that inhibit cell division and survival. (a) Microcin B17Citation285,286, (b) ChitosanCitation200, (c) PyrrhocoricinCitation287, (d) Sodium CitrateCitation288, (e) Tetrasodium EDTACitation289.
![Figure 7. Structures of the anti-biofilm molecules that inhibit cell division and survival. (a) Microcin B17Citation285,286, (b) ChitosanCitation200, (c) PyrrhocoricinCitation287, (d) Sodium CitrateCitation288, (e) Tetrasodium EDTACitation289.](/cms/asset/989509c0-b3b6-44f2-a799-a1181d0e0fb2/kvir_a_1313372_f0007_b.gif)
Figure 8. Structures of the anti-biofilm molecules that Inhibit adhesion molecule synthesis and function (a) Cadexomer iodineCitation290, (b) LL-37291.
![Figure 8. Structures of the anti-biofilm molecules that Inhibit adhesion molecule synthesis and function (a) Cadexomer iodineCitation290, (b) LL-37291.](/cms/asset/13c6e60e-717b-48a8-9a78-efaaef3d6327/kvir_a_1313372_f0008_b.gif)
Figure 9. Structures of the anti-biofilm molecules that inhibit polysaccharides. (a) Psl polysaccharideCitation292,293, (b) Pel polysaccharideCitation294, (c) CFT073 group-II capsular polysaccharide (Serotype K2)Citation295.
![Figure 9. Structures of the anti-biofilm molecules that inhibit polysaccharides. (a) Psl polysaccharideCitation292,293, (b) Pel polysaccharideCitation294, (c) CFT073 group-II capsular polysaccharide (Serotype K2)Citation295.](/cms/asset/fcbe845a-0f66-4ed8-b563-e4d80a63a14e/kvir_a_1313372_f0009_b.gif)
Figure 10. Structures of the antibiofilm molecules with unknown mechanism of action. (a) EsculetinCitation296, b) FisetinCitation297, c) Octenidine hydrochlorideCitation298.
![Figure 10. Structures of the antibiofilm molecules with unknown mechanism of action. (a) EsculetinCitation296, b) FisetinCitation297, c) Octenidine hydrochlorideCitation298.](/cms/asset/ff490c0d-bff0-42c9-a89e-98025c72ed50/kvir_a_1313372_f0010_b.gif)